AbbVie remains strong long-term performer, offering a solid dividend yield and robust revenue growth despite share price dips ...

Good morning, and welcome to AbbVie second quarter 2024 earnings conference call. [Operator instructions] I would now like to introduce Ms. Liz Shea, senior vice president, investor relations. Liz ...

AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

AbbVie ABBV will report second-quarter 2022 results on Jul 29, before market open. In the last reported quarter, the company delivered an earnings surprise of 0.32%.

AbbVie will report Q2 earnings on Thursday. Investors watch for Humira impact and signs of recovery under new CEO.

AbbVie expects full-year earnings in the range of $10.71 to $10.91 per share. AbbVie shares have climbed 14% since the beginning of the year, while the S&P's 500 index has risen 14%.

AbbVie expects full-year earnings in the range of $10.90 to $11.10 per share. AbbVie shares have declined 12% since the beginning of the year, while the S&P’s 500 index has increased 19%.

AbbVie Inc. (NYSE:ABBV) Q2 2024 Earnings Conference Call July 25, 2024 9:00 AM ETCompany ParticipantsLiz Shea - Senior Vice President, Investor RelationsRob ...